These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 19727215)
1. [Specific suppression in regulatory T cells by Foxp3 siRNA contributes to enhance the in vitro anti-tumor immune response in hepatocellular carcinoma patients]. Zhang HH; Fei R; Xie XW; Wang L; Luo H; Wang XY; Wei L; Chen HS Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Jun; 41(3):313-8. PubMed ID: 19727215 [TBL] [Abstract][Full Text] [Related]
2. [Effects of Foxp3 knockdown on the functions of human regulatory T cells]. Sun L; Yi SN; Chen L Zhonghua Yi Xue Za Zhi; 2011 Aug; 91(30):2124-8. PubMed ID: 22093989 [TBL] [Abstract][Full Text] [Related]
3. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses. Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932 [TBL] [Abstract][Full Text] [Related]
4. Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells. Kakita N; Kanto T; Itose I; Kuroda S; Inoue M; Matsubara T; Higashitani K; Miyazaki M; Sakakibara M; Hiramatsu N; Takehara T; Kasahara A; Hayashi N Int J Cancer; 2012 Dec; 131(11):2573-83. PubMed ID: 22419479 [TBL] [Abstract][Full Text] [Related]
5. Regulatory T cell depletion enhances tumor specific CD8 T-cell responses, elicited by tumor antigen NY-ESO-1b in hepatocellular carcinoma patients, in vitro. Zhang HH; Mei MH; Fei R; Liao WJ; Wang XY; Qin LL; Wang JH; Wei L; Chen HS Int J Oncol; 2010 Apr; 36(4):841-8. PubMed ID: 20198327 [TBL] [Abstract][Full Text] [Related]
6. Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma. Shen X; Li N; Li H; Zhang T; Wang F; Li Q J Cancer Res Clin Oncol; 2010 Nov; 136(11):1745-54. PubMed ID: 20221638 [TBL] [Abstract][Full Text] [Related]
7. Increased frequency of Foxp3+ regulatory T cells in mice with hepatocellular carcinoma. Du Y; Chen X; Huang ZM; Ye XH; Niu Q Asian Pac J Cancer Prev; 2012; 13(8):3815-9. PubMed ID: 23098476 [TBL] [Abstract][Full Text] [Related]
8. Amphiregulin activates regulatory T lymphocytes and suppresses CD8+ T cell-mediated anti-tumor response in hepatocellular carcinoma cells. Yuan CH; Sun XM; Zhu CL; Liu SP; Wu L; Chen H; Feng MH; Wu K; Wang FB Oncotarget; 2015 Oct; 6(31):32138-53. PubMed ID: 26451607 [TBL] [Abstract][Full Text] [Related]
9. [The subpopulation CD4(+); CD25(+); Foxp3(+);/CD127(low/-); regulatory T cells in peripheral blood of HIV-infected patients correlated with disease progression]. Chen YL; Chen XR; Qin LX; Yang YF; Tang YM Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Nov; 28(11):1188-91. PubMed ID: 23127412 [TBL] [Abstract][Full Text] [Related]
10. Foxp3 regulates human natural CD4+CD25+ regulatory T-cell-mediated suppression of xenogeneic response. Sun L; Yi S; O'Connell PJ Xenotransplantation; 2010; 17(2):121-30. PubMed ID: 20522244 [TBL] [Abstract][Full Text] [Related]
11. Increased intratumoral regulatory T cells are related to intratumoral macrophages and poor prognosis in hepatocellular carcinoma patients. Zhou J; Ding T; Pan W; Zhu LY; Li L; Zheng L Int J Cancer; 2009 Oct; 125(7):1640-8. PubMed ID: 19569243 [TBL] [Abstract][Full Text] [Related]
12. Increased frequency and FOXP3 expression of human CD8 Zahran AM; Nafady-Hego H; Mansor SG; Abbas WA; Abdel-Malek MO; Mekky MA; Hetta HF Hum Immunol; 2019 Jul; 80(7):510-516. PubMed ID: 30904437 [TBL] [Abstract][Full Text] [Related]
13. The spontaneous CD8+ T-cell response to HLA-A2-restricted NY-ESO-1b peptide in hepatocellular carcinoma patients. Shang XY; Chen HS; Zhang HG; Pang XW; Qiao H; Peng JR; Qin LL; Fei R; Mei MH; Leng XS; Gnjatic S; Ritter G; Simpson AJ; Old LJ; Chen WF Clin Cancer Res; 2004 Oct; 10(20):6946-55. PubMed ID: 15501973 [TBL] [Abstract][Full Text] [Related]
14. Intrahepatic interleukin-17+ T cells and FoxP3+ regulatory T cells cooperate to promote development and affect the prognosis of hepatocellular carcinoma. Huang Y; Wang F; Wang Y; Zhu Z; Gao Y; Ma Z; Xu R; Du Z J Gastroenterol Hepatol; 2014 Apr; 29(4):851-9. PubMed ID: 24303990 [TBL] [Abstract][Full Text] [Related]
15. Human hepatocellular carcinoma-infiltrating CD4⁺CD69⁺Foxp3⁻ regulatory T cell suppresses T cell response via membrane-bound TGF-β1. Han Y; Yang Y; Chen Z; Jiang Z; Gu Y; Liu Y; Xu S; Lin C; Pan Z; Zhou W; Cao X J Mol Med (Berl); 2014 May; 92(5):539-50. PubMed ID: 24668348 [TBL] [Abstract][Full Text] [Related]
16. Decrease of CD4(+) CD25(+) CD127(low) FoxP3(+) regulatory T cells with impaired suppressive function in untreated ulcerative colitis patients. Mohammadnia-Afrouzi M; Zavaran Hosseini A; Khalili A; Abediankenari S; Hosseini V; Maleki I Autoimmunity; 2015; 48(8):556-61. PubMed ID: 26333292 [TBL] [Abstract][Full Text] [Related]
17. Expansion of peripheral and intratumoral regulatory T-cells in hepatocellular carcinoma: a case-control study. Thakur S; Singla A; Chawla Y; Rajwanshi A; Kalra N; Arora SK Indian J Pathol Microbiol; 2011; 54(3):448-53. PubMed ID: 21934201 [TBL] [Abstract][Full Text] [Related]
18. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208 [TBL] [Abstract][Full Text] [Related]
19. GITR ligation enhances functionality of tumor-infiltrating T cells in hepatocellular carcinoma. van Beek AA; Zhou G; Doukas M; Boor PPC; Noordam L; Mancham S; Campos Carrascosa L; van der Heide-Mulder M; Polak WG; Ijzermans JNM; Pan Q; Heirman C; Mahne A; Bucktrout SL; Bruno MJ; Sprengers D; Kwekkeboom J Int J Cancer; 2019 Aug; 145(4):1111-1124. PubMed ID: 30719701 [TBL] [Abstract][Full Text] [Related]
20. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells. Kessel A; Haj T; Peri R; Snir A; Melamed D; Sabo E; Toubi E Autoimmun Rev; 2012 Jul; 11(9):670-7. PubMed ID: 22155204 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]